CRISPR-based DETECTR® assay for faster SARS-CoV-2 surveillance

Researchers from the USA discuss the development and validation of CRISPR-Cas12-based COVID-19 variant DETECTR® assay for the detection of SARS-CoV-2.

Related Keywords

Alexey Boldin Shutterstock , ,Image Credit ,Assay ,Coronavirus Disease Covid 19 ,Rispr ,Cars ,Ars Cov 2 ,Coronavirus ,Nzyme ,Gene ,Immune Response ,Ucleotide ,Palindromic Repeats ,Pandemic ,Espiratory ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Single Nucleotide Polymorphism ,Yndrome ,Virus ,